Revenue: The sum of all revenue fields included for a company's operating activities.
Alseres Pharmaceuticals Inc. (ALSE) had Revenue of $0.47M for the most recently reported fiscal year, ending 2013-12-31.
| Income Statement Financials | |
|
Revenue |
$0.47M |
$-0.94M |
|
-- |
|
$0.47M |
|
$1.04M |
|
$-0.56M |
|
$-0.38M |
|
$-0.94M |
|
$-0.68M |
|
$-0.94M |
|
$-0.94M |
|
$-0.94M |
|
$-0.68M |
|
$-0.56M |
|
$-0.56M |
|
0.01M |
|
0.01M |
|
$-150.00 |
|
$-150.00 |
|
| Balance Sheet Financials | |
$0.32M |
|
-- |
|
$0.06M |
|
$0.39M |
|
$1.65M |
|
$7.82M |
|
$9.40M |
|
$11.05M |
|
$-10.66M |
|
$-10.66M |
|
$-10.66M |
|
0.01M |
|
| Cash Flow Statement Financials | |
$-1.69M |
|
$0.88M |
|
$0.90M |
|
$0.02M |
|
$0.11M |
|
$0.10M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.20 |
|
-- |
|
-- |
|
-2.75 |
|
-0.73 |
|
100.00% |
|
-119.21% |
|
-119.21% |
|
-118.96% |
|
-198.75% |
|
-198.75% |
|
$-1.69M |
|
-- |
|
-- |
|
-- |
|
1.23 |
|
-- |
|
-- |
|
-- |
|
8.83% |
|
8.83% |
|
-244.25% |
|
33.15% |
|
$-1739.75 |
|
$-275.32 |
|
$-275.32 |
|